| Application no. and date | 18759207.6 (espacenet) (Federated) (European Patent Register), 20180803 | | Patent/reg. no. and date | DK/EP 3661954, 20220209 | | Publication date | 20200610 | | Priority no. and date | US 201762540692 P, 20170803, US 201862616733 P, 20180112 | | EP pub. no. and date |
EP 3661954 20200610 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | | Applicant ref. no. | 1622957 | | Inventor | ALI, Khaled, M.K.Z., One Amgen Center Drive
Thousand Oaks
CA 91320, US,
AGRAWAL, Neeraj, Jagdish, One Amgen Center Drive
Thousand Oaks
CA 91320, US,
KANNAN, Gunasekaran, One Amgen Center Drive
Thousand Oaks
CA 91320, US,
FOLTZ, Ian, One Amgen Center Drive
Thousand Oaks
CA 91320, US,
WANG, Zhulun, One Amgen Center Drive
Thousand Oaks
CA 91320, US,
BATES, Daren, One Amgen Center Drive
Thousand Oaks
CA 91320, US,
MOCK, Marissa, One Amgen Center Drive
Thousand Oaks
CA 91320, US,
TAKENAKA, Shunseke, One Amgen Center Drive
Thousand Oaks
CA 91320, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 47/54 (2017.01) , A61K 47/60 (2017.01) , C07K 14/54 (2006.01) | | Title | INTERLEUKIN-21-MUTEINER OG FREMGANGSMÅDER TIL BEHANDLING | | Int. application no. | US2018045105 | | Int. publication no. | WO2019028316 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
